Acute Lymphoblastic Leukemia

About
Mappings

NCI Thesaurus: Acute Lymphoblastic Leukemia (coding:ncit:C3167)

OncoTree: B-Lymphoblastic Leukemia/Lymphoma (coding:oncotree:BLL)

OncoTree: T-Lymphoblastic Leukemia/Lymphoma (coding:oncotree:TLL)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (1) FDA (4) CD19 + Acute Lymphoblastic Leukemia Blinatumomab
EMA (5) FDA (2) CD19 +, not BCR::ABL1 Acute Lymphoblastic Leukemia Blinatumomab
FDA (4) BCR::ABL1 Acute Lymphoblastic Leukemia Dasatinib
FDA (4) CD33 + Acute Lymphoblastic Leukemia Gemtuzumab ozogamicin
FDA (4) BCR::ABL1 Acute Lymphoblastic Leukemia Imatinib
EMA (2) FDA (2) CD22 + Acute Lymphoblastic Leukemia Inotuzumab ozogamicin
EMA (1) FDA (2) BCR::ABL1 Acute Lymphoblastic Leukemia Cytarabine, Dexamethasone, Methotrexate, Ponatinib, Prednisone, Vincristine
FDA (2) ABL1 p.T315I, BCR::ABL1 Acute Lymphoblastic Leukemia Ponatinib
FDA (2) t(KMT2A;v) Acute Lymphoblastic Leukemia Revumenib
EMA (2) CD22 +, not BCR::ABL1 Acute Lymphoblastic Leukemia Inotuzumab ozogamicin
EMA (2) not BCR::ABL1 Acute Lymphoblastic Leukemia Imatinib
EMA (1) not BCR::ABL1 Acute Lymphoblastic Leukemia Ponatinib
EMA (1) ABL1 p.T315I, not BCR::ABL1 Acute Lymphoblastic Leukemia Ponatinib
EMA (2) not BCR::ABL1 Acute Lymphoblastic Leukemia Dasatinib